Lee C, Lin Y, Chang Y, Chen P, Lin K, Yeh T
J Cancer. 2025; 16(5):1694-1708.
PMID: 39991577
PMC: 11843241.
DOI: 10.7150/jca.105425.
Liu Z, Zeng Y, Li R, Yan Y, Yi S, Zhang K
J Thorac Dis. 2024; 16(9):6052-6063.
PMID: 39444855
PMC: 11494543.
DOI: 10.21037/jtd-23-1836.
Gu C, Jin L, Lv X, Wang C, Wen C, Su X
Discov Oncol. 2024; 15(1):535.
PMID: 39382813
PMC: 11464972.
DOI: 10.1007/s12672-024-01421-2.
Luo Y, Ye T, Tian H, Song H, Kan C, Han F
Lipids Health Dis. 2024; 23(1):308.
PMID: 39334359
PMC: 11430456.
DOI: 10.1186/s12944-024-02293-9.
Sun L, Jiao Y, Cui F, Liu J, Xu Z, Sun D
Discov Oncol. 2024; 15(1):449.
PMID: 39278863
PMC: 11402887.
DOI: 10.1007/s12672-024-01317-1.
Pyroptosis, ferroptosis, and autophagy in spinal cord injury: regulatory mechanisms and therapeutic targets.
Zheng Q, Wang D, Lin R, Xu W
Neural Regen Res. 2024; 20(10):2787-2806.
PMID: 39101602
PMC: 11826477.
DOI: 10.4103/NRR.NRR-D-24-00112.
Bone Morphogenetic Protein Signaling Agonist SB4 (BMPSB4) Inhibits Corticotroph Pituitary Neuroendocrine Tumors by Activation of Autophagy via a BMP4/SMADs-Dependent Pathway.
Xu L, Ning R, Du X, Zhang Y, Gu C, Wang B
ACS Pharmacol Transl Sci. 2024; 7(7):1951-1970.
PMID: 39022361
PMC: 11249644.
DOI: 10.1021/acsptsci.4c00021.
Identification of PSMD11 as a novel cuproptosis- and immune-related prognostic biomarker promoting lung adenocarcinoma progression.
Huang Q, Tian R, Yu J, Du W
Cancer Med. 2024; 13(11):e7379.
PMID: 38859698
PMC: 11165170.
DOI: 10.1002/cam4.7379.
Survivin as a Therapeutic Target for the Treatment of Human Cancer.
Wang Q, Greene M
Cancers (Basel). 2024; 16(9).
PMID: 38730657
PMC: 11083197.
DOI: 10.3390/cancers16091705.
Cancer-associated fibroblasts: a versatile mediator in tumor progression, metastasis, and targeted therapy.
Guo T, Xu J
Cancer Metastasis Rev. 2024; 43(3):1095-1116.
PMID: 38602594
PMC: 11300527.
DOI: 10.1007/s10555-024-10186-7.
Exploring effective biomarkers and potential immune related gene in small cell lung cancer.
Yunchu Y, Miyanaga A, Matsuda K, Kamio K, Seike M
Sci Rep. 2024; 14(1):7604.
PMID: 38556560
PMC: 10982305.
DOI: 10.1038/s41598-024-58454-4.
Milk fat globule epidermal growth factor 8 alleviates liver injury in severe acute pancreatitis by restoring autophagy flux and inhibiting ferroptosis in hepatocytes.
Cui Q, Liu H, Liu W, Ma F, Lv Y, Ma J
World J Gastroenterol. 2024; 30(7):728-741.
PMID: 38515944
PMC: 10950629.
DOI: 10.3748/wjg.v30.i7.728.
TET1 inhibits the migration and invasion of cervical cancer cells by regulating autophagy.
Ren J, Chen X, Li J, Zan Y, Wang S, Tan Y
Epigenetics. 2024; 19(1):2323751.
PMID: 38431880
PMC: 10913696.
DOI: 10.1080/15592294.2024.2323751.
Dioscin inhibits non-small cell lung cancer cells and activates apoptosis by downregulation of Survivin.
Wang R, Li X, Gan Y, Liao J, Han S, Li W
J Cancer. 2024; 15(5):1366-1377.
PMID: 38356707
PMC: 10861826.
DOI: 10.7150/jca.89831.
Immune-related gene prognostic index (IRGPI) for lung adenocarcinoma predicts patient prognosis and immunotherapy response.
Zhu Z, Feng W, Tan X, Gu P, Song W, Ma H
Int J Clin Exp Pathol. 2023; 16(10):260-281.
PMID: 37970331
PMC: 10641371.
Downregulated BIRC5 inhibits proliferation and metastasis of melanoma through the β-catenin/HIF-1α/VEGF/MMPs pathway.
He Q, He Y, Li C, Wang J, Xia T, Xiong X
J Cancer Res Clin Oncol. 2023; 149(18):16797-16809.
PMID: 37728702
DOI: 10.1007/s00432-023-05425-3.
Effects of high-risk human papillomavirus infection on P53, pRb, and survivin in lung adenocarcinoma-a retrospective study.
Sun W, Yang H, Cao L, Wu R, Ding B, Liu X
PeerJ. 2023; 11:e15570.
PMID: 37520249
PMC: 10386818.
DOI: 10.7717/peerj.15570.
Progranulin regulation of autophagy contributes to its chondroprotective effect in osteoarthritis.
Pan Y, Yang Y, Fan M, Chen C, Jiang R, Liang L
Genes Dis. 2023; 10(4):1582-1595.
PMID: 37397563
PMC: 10311031.
DOI: 10.1016/j.gendis.2022.05.031.
Nanomedicine for autophagy modulation in cancer therapy: a clinical perspective.
Lopez-Mendez T, Sanchez-Alvarez M, Trionfetti F, Pedraz J, Tripodi M, Cordani M
Cell Biosci. 2023; 13(1):44.
PMID: 36871010
PMC: 9985235.
DOI: 10.1186/s13578-023-00986-9.
Synergistic treatment of osteosarcoma with biomimetic nanoparticles transporting doxorubicin and siRNA.
Zhao J, Mu X, Hou X, Zhang X, Li P, Jiang J
Front Oncol. 2023; 13:1111855.
PMID: 36756155
PMC: 9900173.
DOI: 10.3389/fonc.2023.1111855.